Healthy

• Pharmacokinetics, safety, and efficacy of fisetin - A phase I and pilot phase IIa study Recruiting
  2023-506284-34-00 9 2026-03-24
• Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants Recruiting
  2024-513069-37-00 1 2026-01-30
• Targeting mTOR with everolimus and/or physical training for preventing postmenopausal bone loss and accelerated skeletal aging. The RapaLoad … Recruiting
  2023-508093-28-00 4 2024-10-20
• A Randomised Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability, and … Ended
  2023-504838-21-00 1 2025-01-08
• A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants Ended
  2024-512841-17-00 3 2024-09-04
• A pivotal, randomized, open-label, two-treatment, two-sequence, four periods, crossover clinical trial to evaluate the bioequivalence of sin … Ended
  2023-509484-24-00 2 2024-08-10
• A study in healthy people to test whether iclepertin has an effect on cardiac safety Ended
  2023-504693-38-00 3 2024-01-25
• A study to investigate the pharmacokinetics of remibrutinib in CSF in healthy participants. Ended
  2023-506760-13-00 3 2023-12-11
• A study in healthy people to test how well repeated doses of BI 3032950 are tolerated Ended
  2023-503332-40-00 3 2023-09-05
• A PHASE 1 STUDY TO ASSESS THE EXCRETION BALANCE, PHARMACOKINETICS, AND METABOLISM OF [14C] DC 806 IN HEALTHY MALE PARTICIPANTS. Ended
  2023-505367-36-00 3 2023-08-24
• A study in healthy men to test how BI 1810631 is taken up and processed by the body. Ended
  2022-503047-17-00 3 2023-08-10
• A study in healthy men to test how itraconazole influences the amount of BI 1815368 in the blood Ended
  2023-503783-16-00 3 2023-08-02
• Physiologically based pharmacokinetic modelling of oral and intranasal formulations of zolmitriptan in healthy volunteers Ended
  2023-504492-24-00 3 2023-07-12
• A study to test how well different doses of BI 1815368 are tolerated by healthy men Ended
  2023-503815-13-00 3 2023-06-19
• A Randomized, Open-label, Single Dose, 3-Period, 6-Sequence Cross-Over Trial to Investigate the Relative Bioavailability of Apraglutide Vers … Ended
  2023-504430-22-00 2 2023-05-23
• A study in healthy men to test how BI 764198 is processed in the body Ended
  2022-502327-22-00 3 2023-05-03
• A study in healthy men to test how BI 1291583 is processed in the body Ended
  2022-502264-20-00 3 2023-04-26
• A study in healthy women to test whether BI 425809 influences the amount of a contraceptive in the blood Ended
  2022-500050-42-00 3 2022-11-24

Showing 1–18 of 18 trials